Please assess the completion status of the following clinical trial:

Trial Title: A Dose Titration Study of Fentanyl Buccal Soluble Film for Breakthrough Cancer Pain in Taiwan

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* a. a stable current regimen of oral opioids equivalent to 60-1000 mg/day of oral morphine or 20-120 mg/day of iv morphine or 25-300 mcg/hr of transdermal fentanyl for one week or longer;~* b. regularly experienced 1 to 3 breakthrough pain episodes per day that required additional opioids from pain control;~* c. at least partial relief of breakthrough pain by use of opioid therapy;~* d. 20 years of age or older;~* e. ability to understand and willingness to sign a written informed consent document;~* f. able to self-administer the study medication correctly or has the availability of a responsible adult caregiver available to administer the study medication correctly;~* g. willing and able to complete patient diary with each pain episode~Exclusion Criteria:~* a. rapidly escalating pain (e.g., regularly more than 3 breakthrough pain episodes per day) that are hard to be controlled by analgesics;~* b. history of hypersensitivity or intolerance to fentanyl;~* c. cardiopulmonary disease that, in the opinion of the investigator, would significantly increase the risk of respiratory depression;~* d. psychiatric/cognitive or neurological impairment that would limit the subject's ability to understand or complete the diary;~* e. moderate (Grade 3) to severe (Grade 4) mucositis (subjects with less than moderate mucositis are permitted and must be instructed to not apply the Painkyl® film at a site of inflammation);~* f. abnormal oral mucosa which will impede drug absorption;~* g. currently under other treatments that may alter effect of pain control based on investigator's judgment;~* h. recent history or current evidence of alcohol or other drug substance (licit or illicit) abuse;~* i. use of an investigational drug within 4 weeks preceding this study;~* j. pregnant women or nursing mothers, or positive pregnancy test for women of childbearing potential;

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Fentanyl buccal soluble film (FBSF) (Type: EXPERIMENTAL): Single arm

Based on this trial design, predict the completion outcome and termination type (if applicable).